Viking Therapeutics Research and Development Expense (Quarterly) Analysis

Viking Therapeutics Inc (VKTX)

42.35 +0.03 (+0.07%) USD | NASDAQ | Dec 24, 16:00

View Research and Development Expense (Quarterly) for VKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Research and Development Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View R&D Expense Definition

Start Trial

R&D expense is a line item from many companies' income statements.

View Research and Development Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Research and Development Expense (Quarterly) Benchmarks

Start Trial